1. Daar ES, Little S, Pitt J, et al. Diagnosis of primary HIV-1 infection: Los Angeles county primary HIV infection recruitment network. Ann Intern Med. 2001;134:25-29.
2. Hightow-Weidman LB, Golin CE, Green K, et al. Identifying people with acute HIV infection: demographic features, risk factors, and use of health care among individuals with AHI in North Carolina. AIDS Behav. 2009;13:1075-1083.
3. Richey LE, Halperin J. Acute human immunodeficiency virus infection. Am J Med Sci. 2013;345(2):136-142.
4. Weintraub AC, Giner J, Menezes P, et al. Infrequent diagnosis of primary human immunodeficiency virus infection: missed opportunities in acute care settings. Arch Intern Med. 2003;163:2097-2100.
5. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr . 2005;39:446-453.
6. CDC. Estimated HIV incidence among adults and adolescents in the United States, 2007–2010. www.cdc.gov/hiv/topics/surveillance/resourc es/reports/#supplemental. Accessed April 15, 2014.
7. CDC. National HIV prevention progress report, 2013. www.cdc.gov/hiv/pdf/policies_NationalProgressReport.pdf. Published December 2013. Accessed April 15, 2014.
8. CDC. Draft recommendations: diagnostic laboratory testing for HIV infection in the United States. www.cdc.gov/hiv/pdf/policies_Draft_HIV_Testing_Alg_Rec_508.2.pdf. Accessed April 15, 2014.
9. Kuhar DT, Henderson DK, Struble KA, et al. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol. 2013;34:875-892.
10. Pinkerton SD, Martin JN, Roland ME, et al. Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United States. AIDS . 2004;18:2065-2073.
11. CDC. Update to interim guidance for preexposure prophylaxis (PrEP) for the prevention of HIV infection: PrEP for injecting drug users. MMWR. 2013;62:463-465.
12. Bell DM. Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview. Am J Med . 1997;102(suppl 5B):9-15.
13. CDC. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. MMWR . 2012;61:586-589.
14. CDC. Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR . 2011;60:65-68.
15. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed April 15, 2014.
16. Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009; 360:1815-1826.
17. Castel AD, Magnus M, Peterson J, et al. Implementing a novel citywide rapid HIV testing campaign in Washington, DC: findings and lessons learned. Public Health Rep . 2012;127:422-431.
18. CDC. HIV in the United States: stages of care. www.cdc.gov/hiv/pdf/research_mmp_StagesofCare.pdf. Accessed April 15, 2014.
19. Gardner EM, McLees MP, Steiner JF, et al. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52:793-800.
20. Mugavero MJ, Westfall AO, Zinski A, et al. Retention in Care (RIC) Study Group. Measuring retention in HIV care: the elusive gold standard. J Acquir Immune Defic Syndr. 2012;61:574-580.
21. Fleishman JA, Yehia BR, Moore RD, et al. Establishment, retention, and loss to follow-up in outpatient HIV care. J Acquir Immune Defic Syndr. 2012;60:249-259.
22. Rebeiro P, Althoff KN, Buchacz K, et al. Retention among North American HIV-infected persons in clinical care, 2000-2008. J Acquir Immune Defic Syndr. 2013;62:356-362.
23. American Association for the Study of Liver Diseases. Recommendations for testing, managing, and treating hepatitis C. www.hcvguidelines.org/. Accessed April 15, 2014.
24. Aberg JA, Gallant JE, Ghanem KG, et al. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2014;58:e1-e34.
25. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493-505.
26. Panel on Antiretroviral Guidelines for Adults and Adolescents. Recommendation on integrase inhibitor use in antiretroviral treatment-naive HIV-infected individuals from the HHS panel on antiretroviral guidelines for adults and adolescents. http://aidsinfo.nih.gov/contentfiles/upload/AdultARV_INSTIRecommendations.pdf. Updated 2013. Accessed April 15, 2014.
27. Chesney MA. The elusive gold standard: future perspectives for HIV adherence assessment and intervention. J Acquir Immune Defic Syndr. 2006;43(suppl 1):S149-155.
